Current Liabilities
Accrued Expenses
Merck & Co. Accrued Expenses increased by 2.4% to $42.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 2.4%, from $41.00M to $42.00M. Over 5 years (FY 2020 to FY 2025), Accrued Expenses shows a downward trend with a -8.9% CAGR.
Analysis
StatementBalance Sheet Statement
SectionCurrent Liabilities
CategoryLiquidity
SignalContext dependent
VolatilityModerate
First reportedQ4 2015
Last reportedQ1 2026
How to read this metric
A steady balance is normal, but a rapid increase could indicate rising operational costs or delays in vendor invoicing.
Detailed definition
This represents liabilities for expenses that have been incurred but not yet invoiced or paid, such as utilities, profes...
Peer comparison
Standard current liability found in almost all corporate balance sheets.
Metric ID:
accrued_expensesHistorical Data
5 periods
| Q4 '21 | Q4 '22 | Q4 '23 | Q4 '24 | Q4 '25 | |
|---|---|---|---|---|---|
| Value | $40.00M | $39.00M | $42.00M | $41.00M | $42.00M |
| QoQ Change | — | -2.5% | +7.7% | -2.4% | +2.4% |
| YoY Change | — | -2.5% | +7.7% | -2.4% | +2.4% |
Range$39.00M – $42.00M
CAGR+5.0%
Avg YoY Growth+1.3%
Median YoY Growth+0.0%
Accrued Expenses at Other Companies
Frequently Asked Questions
- What is Merck & Co.'s accrued expenses?
- Merck & Co. (MRK) reported accrued expenses of $42.00M in Q4 2025.
- How has Merck & Co.'s accrued expenses changed year-over-year?
- Merck & Co.'s accrued expenses increased by 2.4% year-over-year, from $41.00M to $42.00M.
- What is the long-term trend for Merck & Co.'s accrued expenses?
- Over 5 years (2020 to 2025), Merck & Co.'s accrued expenses has grown at a -8.9% compound annual growth rate (CAGR), from $67.00M to $42.00M.
- What does accrued expenses mean?
- Expenses the company has incurred but has not yet received a bill for or paid.